DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Collagenase clostridium histolyticum is an investigational drug.
There have been 16 clinical trials for Collagenase clostridium histolyticum. The most recent clinical trial was a Phase 3 trial, which was initiated on March 20th 2018.
The most common disease conditions in clinical trials are Dupuytren Contracture, Contracture, and Lipoma. The leading clinical trial sponsors are Advance Biofactures Corporation, Endo Pharmaceuticals, and Tampere University Hospital.
There are seven US patents protecting this investigational drug and one hundred and ninety-three international patents.
Recent Clinical Trials for Collagenase clostridium histolyticum
|Collagenase Clostridium Histolyticum for Refractory Iatrogenic Esophageal Strictures||University Hospital, Ghent||Early Phase 1|
|Xiaflex® Plus Testosterone Treatment Pilot Study Protocol||Men's Health Boston||Phase 4|
|Injection Techniques of EN3835 for the Treatment of EFP (Commonly Known as Cellulite)||Endo Pharmaceuticals||Phase 2|
Top disease conditions for Collagenase clostridium histolyticum
Top clinical trial sponsors for Collagenase clostridium histolyticum
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Collagenase clostridium histolyticum||Start Trial||Treatment method and product for uterine fibroids using purified collagenase||BioSpecifics Technologies Corporation (Lynbrook, NY) Duke University (Durham, NC)||Start Trial|
|Collagenase clostridium histolyticum||Start Trial||Postpartum cells isolated from umbilical cord tissue, and methods of making and using the same||Ethicon, Incorporated (Somerville, NJ)||Start Trial|
|Collagenase clostridium histolyticum||Start Trial||Skincare methods||Asan Laboratories Company (Cayman) Limited (Taipei, TW)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Collagenase clostridium histolyticum||Australia||2014228477||2033-03-15||Start Trial|
|Collagenase clostridium histolyticum||Australia||2015206597||2033-03-15||Start Trial|
|Collagenase clostridium histolyticum||Australia||2015261743||2033-03-15||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|